Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (81-90 of 280) with videos related to

Pageof 28
Sort By:
Blood Advances|May 7, 2025
Clec12a is required for the pathogenesis of NUP98::NSD1 AMLSagarajit Mohanty, Fiorella Charles Cano, Razif Gabdoulline, et al.
Biomaterials|February 18, 2014
All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinaseTobias Maetzig, Johannes Kuehle, Adrian Schwarzer, et al.
Haematologica|November 4, 2005
Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemiaMichael Heuser, Luzie U Wingen, Doris Steinemann, et al.
Pediatric Blood & Cancer|June 8, 2021
Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6Uwe Kordes, Victor-Felix Mautner, Florian Oyen, et al.
British Journal of Haematology|May 10, 2012
ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemiaFrederik Damm, Katharina Wagner, Kerstin Görlich, et al.
Leukemia Research|August 14, 2009
An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemiaWalter Fiedler, Rolf Mesters, Michael Heuser, et al.
Annals of Hematology|July 25, 2020
Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-upRabia Shahswar, Gernot Beutel, Razif Gabdoulline, et al.
Frontiers in Oncology|July 25, 2022
Clonal Evolution at First Sight: A Combined Visualization of Diverse Diagnostic Methods Improves Understanding of Leukemic ProgressionSarah Sandmann, Yvonne Lisa Behrens, Claudia Davenport, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 6, 2025
The need for IT specialists in radiation oncology - A position paper by the International Society for radiation oncology Informatics, endorsed by DGMP, SASRO, ÖGRO, ÖGMP, SRO and DEGROSamuel Peters, Marco Meinschad, Fabio Dennstädt, et al.
Blood|February 15, 2019
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantationNico Gagelmann, Markus Ditschkowski, Rashit Bogdanov, et al.
Pageof 28

Showing results (81-90 of 280) with videos related to

Sort By:
Pageof 28
Blood Advances|May 7, 2025
Clec12a is required for the pathogenesis of NUP98::NSD1 AMLSagarajit Mohanty, Fiorella Charles Cano, Razif Gabdoulline, et al.
Biomaterials|February 18, 2014
All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinaseTobias Maetzig, Johannes Kuehle, Adrian Schwarzer, et al.
Haematologica|November 4, 2005
Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemiaMichael Heuser, Luzie U Wingen, Doris Steinemann, et al.
Pediatric Blood & Cancer|June 8, 2021
Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6Uwe Kordes, Victor-Felix Mautner, Florian Oyen, et al.
British Journal of Haematology|May 10, 2012
ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemiaFrederik Damm, Katharina Wagner, Kerstin Görlich, et al.
Leukemia Research|August 14, 2009
An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemiaWalter Fiedler, Rolf Mesters, Michael Heuser, et al.
Annals of Hematology|July 25, 2020
Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-upRabia Shahswar, Gernot Beutel, Razif Gabdoulline, et al.
Frontiers in Oncology|July 25, 2022
Clonal Evolution at First Sight: A Combined Visualization of Diverse Diagnostic Methods Improves Understanding of Leukemic ProgressionSarah Sandmann, Yvonne Lisa Behrens, Claudia Davenport, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 6, 2025
The need for IT specialists in radiation oncology - A position paper by the International Society for radiation oncology Informatics, endorsed by DGMP, SASRO, ÖGRO, ÖGMP, SRO and DEGROSamuel Peters, Marco Meinschad, Fabio Dennstädt, et al.
Blood|February 15, 2019
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantationNico Gagelmann, Markus Ditschkowski, Rashit Bogdanov, et al.
Pageof 28